Epidemics · 2026
Measuring the growth of infectious disease modelling publications and their impact on policymaking: A large language model-assisted bibliometric review.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Christen Paula, Ahmed Malik H A, Chua Brandon Wen Bing, Chaowanasawat Panupong, Chapman-Banks Emma, Ozkan Yusuf, van Elsland Sabine L, Cori Anne, K C Sarin, Whitaker Matthew D, Chadeau-Hyam Marc, Dabak Saudamini Vishwanath, Jit Mark
Аннотация
BACKGROUND: Infectious disease modelling (IDM) is increasingly used to understand disease transmission and inform public health policy. Its growth and influence on policy have not been quantified, partly due to the large volume of literature. Using a large language model (LLM)-assisted review, we quantified the expansion of IDM publications, trends in policy citations, and regional disparities in research contributions and uptake.
METHODS: An LLM-assisted bibliometric review was conducted in Embase, Medline, and Scopus, identifying IDM publications to December 2024 via GPT-4o (OpenAI). Eligible studies employed mathematical, statistical, or mechanistic models for infectious disease outcomes. LLM accuracy was iteratively refined through human review. We extracted publication metadata, geographic scope, and policy citations via Overton, a global database of policy documents. Growth trends were analysed using negative binomial regression; geographic disparities were assessed by World Bank income classifications.
RESULTS: We identified 33,255 IDM publications over 44 years, with distinct growth phases. Publication volume rose with the emergence of HIV/AIDS, expanded through successive outbreaks (Ebola, SARS, H1N1, MERS, Zika), surged just before COVID-19, then declined after 2021. Policy citations accounted for 1.7% of IDM publications, mirroring overall growth and peaking during periods of heightened public health attention. Citations largely reflected national research outputs, with some cross-regional adoption of IDM evidence.
CONCLUSION: Strengthening IDM's policy impact may require fostering collaboration pu and improving uptake mechanisms. Post-COVID-19, policy citations declined despite continued IDM growth, suggesting a lag or shift in priorities.
METHODS: An LLM-assisted bibliometric review was conducted in Embase, Medline, and Scopus, identifying IDM publications to December 2024 via GPT-4o (OpenAI). Eligible studies employed mathematical, statistical, or mechanistic models for infectious disease outcomes. LLM accuracy was iteratively refined through human review. We extracted publication metadata, geographic scope, and policy citations via Overton, a global database of policy documents. Growth trends were analysed using negative binomial regression; geographic disparities were assessed by World Bank income classifications.
RESULTS: We identified 33,255 IDM publications over 44 years, with distinct growth phases. Publication volume rose with the emergence of HIV/AIDS, expanded through successive outbreaks (Ebola, SARS, H1N1, MERS, Zika), surged just before COVID-19, then declined after 2021. Policy citations accounted for 1.7% of IDM publications, mirroring overall growth and peaking during periods of heightened public health attention. Citations largely reflected national research outputs, with some cross-regional adoption of IDM evidence.
CONCLUSION: Strengthening IDM's policy impact may require fostering collaboration pu and improving uptake mechanisms. Post-COVID-19, policy citations declined despite continued IDM growth, suggesting a lag or shift in priorities.